Citation 7948
LALE,A: HERBERT,JM: AUGEREAU,JM: BILLON,M: LECONTE,M: GLEYE,J:. (1996). ABILITY OF DIFFERENT FLAVONOIDS TO INHIBIT THE PROCOAGULANT ACTIVITY OF ADHERENT HUMAN MONOCYTES.. 59(3)
Citation Details
| Title | ABILITY OF DIFFERENT FLAVONOIDS TO INHIBIT THE PROCOAGULANT ACTIVITY OF ADHERENT HUMAN MONOCYTES. |
|---|---|
| Authors | LALE,A: HERBERT,JM: AUGEREAU,JM: BILLON,M: LECONTE,M: GLEYE,J: |
| Year | 1996 |
| Volume | 59 |
| Issue | 3 |
Summary
Year: 1996
Journal: Unknown
Organisms and Their Experiments (1)
Unknown organism
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 |
ANTICOAGULANT ACTIVITY
|
INACTIVE
|
||
| 2 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 3 |
ANTICOAGULANT ACTIVITY
|
STRONG ACTIVITY
|
||
| 4 |
ANTICOAGULANT ACTIVITY
|
STRONG ACTIVITY
|
||
| 5 |
ANTICOAGULANT ACTIVITY
|
ROBINETIN,DIHYDRO:HESPERIDIN,NEO:NARIRUTINEUPATORIN-5-METHYL ETHERFLAVONE,4-METHOXY:VITEXIN-2-O-RHAMNOSIDEKAEMPFEROL-4'-7-DIMETHOXY-8-BUTYRYL ESTERPINOCEMBRIN,7-METHOXY:MORINQUERCETINQUERCETAGETINSILYBINEUPATORINTANGERETINFUSTINGARDENIN AFLAVONE,5-7-DIHYDROXY-3'-4'-5'-TRIMETHOXY:RHAMNETINERIODICTYOL,HOMO:SAKURANETIN,ISO:AVICULARINASTRAGALINGALANGINFLAVANONE
|
INACTIVE
|
|
| 6 |
ANTICOAGULANT ACTIVITY
|
WEAK ACTIVITY
|
||
| 7 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 8 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 9 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 10 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 11 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 12 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 13 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 14 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 15 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 16 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 17 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 18 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 19 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 20 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 21 |
ANTICOAGULANT ACTIVITY
|
WEAK ACTIVITY
|
||
| 22 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 23 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 24 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 25 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 26 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 27 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 28 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 29 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 30 |
ANTICOAGULANT ACTIVITY
|
WEAK ACTIVITY
|
||
| 31 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 32 |
ANTICOAGULANT ACTIVITY
|
WEAK ACTIVITY
|
||
| 33 |
ANTICOAGULANT ACTIVITY
|
WEAK ACTIVITY
|
||
| 34 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 35 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 36 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 37 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|
||
| 38 |
ANTICOAGULANT ACTIVITY
|
ACTIVE
|